Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now
Banasmita is skilled in technology scouting, partner identification, competitor benchmarking, and market analysis, with a strong focus on business development and technology innovation to deliver tailored solutions and drive growth.
The Challenge Business development and licensing teams frequently encounter a common issue: an abundance of late-stage assets in databases and presentations. The real gap lies in identifying assets that are
The pharma industry generates an estimated 25–100 kg of chemical waste per kilogram of active drug produced, and most of that waste is solvent. It is the starting point for
Over the past 24 months, OTC leaders have made a quiet but telling shift. Neutrogena is no longer just selling topical skincare; it has launched AI-powered, personalized ingestible solutions. Haleon
The European Commission has recently postponed the ban on TiO2 in medicinal products due to the lack of viable alternatives. This move highlights the overreliance on TiO2 and the need
In August 2025, the Microbiome Therapeutics Innovation Group (MTIG) petitioned the FDA to end the “IND loophole”. It’s a policy that allowed doctors to use unapproved stool-based (gut bacteria) treatments
